 | • レポートコード：MRC2-11QY01563 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は封入体筋炎のグローバル市場について調査・分析したレポートです。種類別（ACE-083、アセヌラミン酸ER、ALZ-1903、UX-001P、UX-007、その他）市場規模、用途別（研究センター、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別封入体筋炎の競争状況、市場シェア ・世界の封入体筋炎市場：種類別市場規模 2015年-2020年（ACE-083、アセヌラミン酸ER、ALZ-1903、UX-001P、UX-007、その他） ・世界の封入体筋炎市場：種類別市場規模予測 2021年-2026年（ACE-083、アセヌラミン酸ER、ALZ-1903、UX-001P、UX-007、その他） ・世界の封入体筋炎市場：用途別市場規模 2015年-2020年（研究センター、病院、クリニック） ・世界の封入体筋炎市場：用途別市場規模予測 2021年-2026年（研究センター、病院、クリニック） ・北米の封入体筋炎市場分析：米国、カナダ ・ヨーロッパの封入体筋炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの封入体筋炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の封入体筋炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの封入体筋炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acceleron Pharma Inc、KPI Therapeutics Inc、Milo Biotechnology LLC、Nobelpharma Co Ltd、Orphazyme ApS、Ultragenyx Pharmaceutical Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Inclusion Body Myositis Market
The global Inclusion Body Myositis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Inclusion Body Myositis Scope and Market Size
Inclusion Body Myositis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inclusion Body Myositis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Inclusion Body Myositis market is segmented into
ACE-083
Aceneuramic Acid ER
ALZ-1903
UX-001P
UX-007
Others
Segment by Application, the Inclusion Body Myositis market is segmented into
Research Center
Hospital
Clinic
Regional and Country-level Analysis
The Inclusion Body Myositis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Inclusion Body Myositis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inclusion Body Myositis Market Share Analysis
Inclusion Body Myositis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inclusion Body Myositis business, the date to enter into the Inclusion Body Myositis market, Inclusion Body Myositis product introduction, recent developments, etc.
The major vendors covered:
Acceleron Pharma Inc
KPI Therapeutics Inc
Milo Biotechnology LLC
Nobelpharma Co Ltd
Orphazyme ApS
Ultragenyx Pharmaceutical Inc
…
1 Study Coverage
1.1 Inclusion Body Myositis Product Introduction
1.2 Market Segments
1.3 Key Inclusion Body Myositis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Inclusion Body Myositis Market Size Growth Rate by Type
1.4.2 ACE-083
1.4.3 Aceneuramic Acid ER
1.4.4 ALZ-1903
1.4.5 UX-001P
1.4.6 UX-007
1.4.7 Others
1.5 Market by Application
1.5.1 Global Inclusion Body Myositis Market Size Growth Rate by Application
1.5.2 Research Center
1.5.3 Hospital
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Inclusion Body Myositis Market Size, Estimates and Forecasts
2.1.1 Global Inclusion Body Myositis Revenue 2015-2026
2.1.2 Global Inclusion Body Myositis Sales 2015-2026
2.2 Global Inclusion Body Myositis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Inclusion Body Myositis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Inclusion Body Myositis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Inclusion Body Myositis Competitor Landscape by Players
3.1 Inclusion Body Myositis Sales by Manufacturers
3.1.1 Inclusion Body Myositis Sales by Manufacturers (2015-2020)
3.1.2 Inclusion Body Myositis Sales Market Share by Manufacturers (2015-2020)
3.2 Inclusion Body Myositis Revenue by Manufacturers
3.2.1 Inclusion Body Myositis Revenue by Manufacturers (2015-2020)
3.2.2 Inclusion Body Myositis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Inclusion Body Myositis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Inclusion Body Myositis Revenue in 2019
3.2.5 Global Inclusion Body Myositis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Inclusion Body Myositis Price by Manufacturers
3.4 Inclusion Body Myositis Manufacturing Base Distribution, Product Types
3.4.1 Inclusion Body Myositis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inclusion Body Myositis Product Type
3.4.3 Date of International Manufacturers Enter into Inclusion Body Myositis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inclusion Body Myositis Market Size by Type (2015-2020)
4.1.1 Global Inclusion Body Myositis Sales by Type (2015-2020)
4.1.2 Global Inclusion Body Myositis Revenue by Type (2015-2020)
4.1.3 Inclusion Body Myositis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Inclusion Body Myositis Market Size Forecast by Type (2021-2026)
4.2.1 Global Inclusion Body Myositis Sales Forecast by Type (2021-2026)
4.2.2 Global Inclusion Body Myositis Revenue Forecast by Type (2021-2026)
4.2.3 Inclusion Body Myositis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Inclusion Body Myositis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Inclusion Body Myositis Market Size by Application (2015-2020)
5.1.1 Global Inclusion Body Myositis Sales by Application (2015-2020)
5.1.2 Global Inclusion Body Myositis Revenue by Application (2015-2020)
5.1.3 Inclusion Body Myositis Price by Application (2015-2020)
5.2 Inclusion Body Myositis Market Size Forecast by Application (2021-2026)
5.2.1 Global Inclusion Body Myositis Sales Forecast by Application (2021-2026)
5.2.2 Global Inclusion Body Myositis Revenue Forecast by Application (2021-2026)
5.2.3 Global Inclusion Body Myositis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Inclusion Body Myositis by Country
6.1.1 North America Inclusion Body Myositis Sales by Country
6.1.2 North America Inclusion Body Myositis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Inclusion Body Myositis Market Facts & Figures by Type
6.3 North America Inclusion Body Myositis Market Facts & Figures by Application
7 Europe
7.1 Europe Inclusion Body Myositis by Country
7.1.1 Europe Inclusion Body Myositis Sales by Country
7.1.2 Europe Inclusion Body Myositis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Inclusion Body Myositis Market Facts & Figures by Type
7.3 Europe Inclusion Body Myositis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Inclusion Body Myositis by Region
8.1.1 Asia Pacific Inclusion Body Myositis Sales by Region
8.1.2 Asia Pacific Inclusion Body Myositis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Inclusion Body Myositis Market Facts & Figures by Type
8.3 Asia Pacific Inclusion Body Myositis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Inclusion Body Myositis by Country
9.1.1 Latin America Inclusion Body Myositis Sales by Country
9.1.2 Latin America Inclusion Body Myositis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Inclusion Body Myositis Market Facts & Figures by Type
9.3 Central & South America Inclusion Body Myositis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Inclusion Body Myositis by Country
10.1.1 Middle East and Africa Inclusion Body Myositis Sales by Country
10.1.2 Middle East and Africa Inclusion Body Myositis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Inclusion Body Myositis Market Facts & Figures by Type
10.3 Middle East and Africa Inclusion Body Myositis Market Facts & Figures by Application
11 Company Profiles
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Inclusion Body Myositis Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
11.2 KPI Therapeutics Inc
11.2.1 KPI Therapeutics Inc Corporation Information
11.2.2 KPI Therapeutics Inc Description and Business Overview
11.2.3 KPI Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 KPI Therapeutics Inc Inclusion Body Myositis Products Offered
11.2.5 KPI Therapeutics Inc Related Developments
11.3 Milo Biotechnology LLC
11.3.1 Milo Biotechnology LLC Corporation Information
11.3.2 Milo Biotechnology LLC Description and Business Overview
11.3.3 Milo Biotechnology LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Milo Biotechnology LLC Inclusion Body Myositis Products Offered
11.3.5 Milo Biotechnology LLC Related Developments
11.4 Nobelpharma Co Ltd
11.4.1 Nobelpharma Co Ltd Corporation Information
11.4.2 Nobelpharma Co Ltd Description and Business Overview
11.4.3 Nobelpharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Nobelpharma Co Ltd Inclusion Body Myositis Products Offered
11.4.5 Nobelpharma Co Ltd Related Developments
11.5 Orphazyme ApS
11.5.1 Orphazyme ApS Corporation Information
11.5.2 Orphazyme ApS Description and Business Overview
11.5.3 Orphazyme ApS Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Orphazyme ApS Inclusion Body Myositis Products Offered
11.5.5 Orphazyme ApS Related Developments
11.6 Ultragenyx Pharmaceutical Inc
11.6.1 Ultragenyx Pharmaceutical Inc Corporation Information
11.6.2 Ultragenyx Pharmaceutical Inc Description and Business Overview
11.6.3 Ultragenyx Pharmaceutical Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Products Offered
11.6.5 Ultragenyx Pharmaceutical Inc Related Developments
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Inclusion Body Myositis Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Inclusion Body Myositis Market Estimates and Projections by Region
12.1.1 Global Inclusion Body Myositis Sales Forecast by Regions 2021-2026
12.1.2 Global Inclusion Body Myositis Revenue Forecast by Regions 2021-2026
12.2 North America Inclusion Body Myositis Market Size Forecast (2021-2026)
12.2.1 North America: Inclusion Body Myositis Sales Forecast (2021-2026)
12.2.2 North America: Inclusion Body Myositis Revenue Forecast (2021-2026)
12.2.3 North America: Inclusion Body Myositis Market Size Forecast by Country (2021-2026)
12.3 Europe Inclusion Body Myositis Market Size Forecast (2021-2026)
12.3.1 Europe: Inclusion Body Myositis Sales Forecast (2021-2026)
12.3.2 Europe: Inclusion Body Myositis Revenue Forecast (2021-2026)
12.3.3 Europe: Inclusion Body Myositis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Inclusion Body Myositis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Inclusion Body Myositis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Inclusion Body Myositis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Inclusion Body Myositis Market Size Forecast by Region (2021-2026)
12.5 Latin America Inclusion Body Myositis Market Size Forecast (2021-2026)
12.5.1 Latin America: Inclusion Body Myositis Sales Forecast (2021-2026)
12.5.2 Latin America: Inclusion Body Myositis Revenue Forecast (2021-2026)
12.5.3 Latin America: Inclusion Body Myositis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Inclusion Body Myositis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Inclusion Body Myositis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Inclusion Body Myositis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Inclusion Body Myositis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Inclusion Body Myositis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inclusion Body Myositis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Inclusion Body Myositis Market Segments
Table 2. Ranking of Global Top Inclusion Body Myositis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Inclusion Body Myositis Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ACE-083
Table 5. Major Manufacturers of Aceneuramic Acid ER
Table 6. Major Manufacturers of ALZ-1903
Table 7. Major Manufacturers of UX-001P
Table 8. Major Manufacturers of UX-007
Table 9. Major Manufacturers of Others
Table 10. Global Inclusion Body Myositis Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Inclusion Body Myositis Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Inclusion Body Myositis Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Inclusion Body Myositis Sales Market Share by Regions (2015-2020)
Table 14. Global Inclusion Body Myositis Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Inclusion Body Myositis Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Inclusion Body Myositis Sales Share by Manufacturers (2015-2020)
Table 17. Global Inclusion Body Myositis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Inclusion Body Myositis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inclusion Body Myositis as of 2019)
Table 19. Inclusion Body Myositis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Inclusion Body Myositis Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Inclusion Body Myositis Price (2015-2020) (USD/Pcs)
Table 22. Inclusion Body Myositis Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Inclusion Body Myositis Product Type
Table 24. Date of International Manufacturers Enter into Inclusion Body Myositis Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 27. Global Inclusion Body Myositis Sales Share by Type (2015-2020)
Table 28. Global Inclusion Body Myositis Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Inclusion Body Myositis Revenue Share by Type (2015-2020)
Table 30. Inclusion Body Myositis Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 32. Global Inclusion Body Myositis Sales Share by Application (2015-2020)
Table 33. North America Inclusion Body Myositis Sales by Country (2015-2020) (K Pcs)
Table 34. North America Inclusion Body Myositis Sales Market Share by Country (2015-2020)
Table 35. North America Inclusion Body Myositis Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Inclusion Body Myositis Revenue Market Share by Country (2015-2020)
Table 37. North America Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 38. North America Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Table 39. North America Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 40. North America Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Table 41. Europe Inclusion Body Myositis Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Inclusion Body Myositis Sales Market Share by Country (2015-2020)
Table 43. Europe Inclusion Body Myositis Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Inclusion Body Myositis Revenue Market Share by Country (2015-2020)
Table 45. Europe Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Table 47. Europe Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Inclusion Body Myositis Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Inclusion Body Myositis Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Inclusion Body Myositis Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Inclusion Body Myositis Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Table 57. Latin America Inclusion Body Myositis Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Inclusion Body Myositis Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Inclusion Body Myositis Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Inclusion Body Myositis Revenue Market Share by Country (2015-2020)
Table 61. Latin America Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Table 63. Latin America Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Inclusion Body Myositis Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Inclusion Body Myositis Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Inclusion Body Myositis Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Inclusion Body Myositis Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Inclusion Body Myositis Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Inclusion Body Myositis Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Table 73. Acceleron Pharma Inc Corporation Information
Table 74. Acceleron Pharma Inc Description and Major Businesses
Table 75. Acceleron Pharma Inc Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Acceleron Pharma Inc Product
Table 77. Acceleron Pharma Inc Recent Development
Table 78. KPI Therapeutics Inc Corporation Information
Table 79. KPI Therapeutics Inc Description and Major Businesses
Table 80. KPI Therapeutics Inc Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. KPI Therapeutics Inc Product
Table 82. KPI Therapeutics Inc Recent Development
Table 83. Milo Biotechnology LLC Corporation Information
Table 84. Milo Biotechnology LLC Description and Major Businesses
Table 85. Milo Biotechnology LLC Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Milo Biotechnology LLC Product
Table 87. Milo Biotechnology LLC Recent Development
Table 88. Nobelpharma Co Ltd Corporation Information
Table 89. Nobelpharma Co Ltd Description and Major Businesses
Table 90. Nobelpharma Co Ltd Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Nobelpharma Co Ltd Product
Table 92. Nobelpharma Co Ltd Recent Development
Table 93. Orphazyme ApS Corporation Information
Table 94. Orphazyme ApS Description and Major Businesses
Table 95. Orphazyme ApS Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Orphazyme ApS Product
Table 97. Orphazyme ApS Recent Development
Table 98. Ultragenyx Pharmaceutical Inc Corporation Information
Table 99. Ultragenyx Pharmaceutical Inc Description and Major Businesses
Table 100. Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Ultragenyx Pharmaceutical Inc Product
Table 102. Ultragenyx Pharmaceutical Inc Recent Development
Table 103. Global Inclusion Body Myositis Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Inclusion Body Myositis Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Inclusion Body Myositis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Inclusion Body Myositis Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Inclusion Body Myositis Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Inclusion Body Myositis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Inclusion Body Myositis Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Inclusion Body Myositis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Inclusion Body Myositis Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Inclusion Body Myositis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Inclusion Body Myositis Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Inclusion Body Myositis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Inclusion Body Myositis Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Inclusion Body Myositis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Inclusion Body Myositis Players
Table 121. Inclusion Body Myositis Customers List
Table 122. Inclusion Body Myositis Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Inclusion Body Myositis Product Picture
Figure 2. Global Inclusion Body Myositis Sales Market Share by Type in 2020 & 2026
Figure 3. ACE-083 Product Picture
Figure 4. Aceneuramic Acid ER Product Picture
Figure 5. ALZ-1903 Product Picture
Figure 6. UX-001P Product Picture
Figure 7. UX-007 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Inclusion Body Myositis Sales Market Share by Application in 2020 & 2026
Figure 10. Research Center
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Inclusion Body Myositis Report Years Considered
Figure 14. Global Inclusion Body Myositis Market Size 2015-2026 (US$ Million)
Figure 15. Global Inclusion Body Myositis Sales 2015-2026 (K Pcs)
Figure 16. Global Inclusion Body Myositis Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Inclusion Body Myositis Sales Market Share by Region (2015-2020)
Figure 18. Global Inclusion Body Myositis Sales Market Share by Region in 2019
Figure 19. Global Inclusion Body Myositis Revenue Market Share by Region (2015-2020)
Figure 20. Global Inclusion Body Myositis Revenue Market Share by Region in 2019
Figure 21. Global Inclusion Body Myositis Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Inclusion Body Myositis Revenue in 2019
Figure 23. Inclusion Body Myositis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Inclusion Body Myositis Sales Market Share by Type (2015-2020)
Figure 25. Global Inclusion Body Myositis Sales Market Share by Type in 2019
Figure 26. Global Inclusion Body Myositis Revenue Market Share by Type (2015-2020)
Figure 27. Global Inclusion Body Myositis Revenue Market Share by Type in 2019
Figure 28. Global Inclusion Body Myositis Market Share by Price Range (2015-2020)
Figure 29. Global Inclusion Body Myositis Sales Market Share by Application (2015-2020)
Figure 30. Global Inclusion Body Myositis Sales Market Share by Application in 2019
Figure 31. Global Inclusion Body Myositis Revenue Market Share by Application (2015-2020)
Figure 32. Global Inclusion Body Myositis Revenue Market Share by Application in 2019
Figure 33. North America Inclusion Body Myositis Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Inclusion Body Myositis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Inclusion Body Myositis Sales Market Share by Country in 2019
Figure 36. North America Inclusion Body Myositis Revenue Market Share by Country in 2019
Figure 37. U.S. Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Inclusion Body Myositis Market Share by Type in 2019
Figure 42. North America Inclusion Body Myositis Market Share by Application in 2019
Figure 43. Europe Inclusion Body Myositis Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Inclusion Body Myositis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Inclusion Body Myositis Sales Market Share by Country in 2019
Figure 46. Europe Inclusion Body Myositis Revenue Market Share by Country in 2019
Figure 47. Germany Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Inclusion Body Myositis Market Share by Type in 2019
Figure 58. Europe Inclusion Body Myositis Market Share by Application in 2019
Figure 59. Asia Pacific Inclusion Body Myositis Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Inclusion Body Myositis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Inclusion Body Myositis Sales Market Share by Region in 2019
Figure 62. Asia Pacific Inclusion Body Myositis Revenue Market Share by Region in 2019
Figure 63. China Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Inclusion Body Myositis Market Share by Type in 2019
Figure 86. Asia Pacific Inclusion Body Myositis Market Share by Application in 2019
Figure 87. Latin America Inclusion Body Myositis Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Inclusion Body Myositis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Inclusion Body Myositis Sales Market Share by Country in 2019
Figure 90. Latin America Inclusion Body Myositis Revenue Market Share by Country in 2019
Figure 91. Mexico Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Inclusion Body Myositis Market Share by Type in 2019
Figure 98. Latin America Inclusion Body Myositis Market Share by Application in 2019
Figure 99. Middle East and Africa Inclusion Body Myositis Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Inclusion Body Myositis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Inclusion Body Myositis Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Inclusion Body Myositis Revenue Market Share by Country in 2019
Figure 103. Turkey Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Inclusion Body Myositis Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Inclusion Body Myositis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Inclusion Body Myositis Market Share by Type in 2019
Figure 110. Middle East and Africa Inclusion Body Myositis Market Share by Application in 2019
Figure 111. North America Inclusion Body Myositis Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Inclusion Body Myositis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Inclusion Body Myositis Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Inclusion Body Myositis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Inclusion Body Myositis Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Inclusion Body Myositis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Inclusion Body Myositis Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Inclusion Body Myositis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Inclusion Body Myositis Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Inclusion Body Myositis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
体形矯正の世界市場（～2026年） Body contouring is a procedure involves in the alteration of the body part by improving the appearance. It refer to removal of the excess body fat. The various body contouring procedures available are body lift, bra line back lift, body fat transfer, implants and abdominal etching. Body lift is the …- ボディ・四肢用美容処置の世界市場（～2026年） Body & extremities aesthetic procedure is a cosmetic procedures involving the lower body and extremities through surgical and medical techniques for lifting, augmentation, reduction, or improvement of a body part. Both surgical and non-surgical strategies are thought to be suitable treatment choices…
- ボディエリアネットワーク（BAN）の世界市場（～2026年） Market Analysis and Insights: Global Body Area Network Market The global Body Area Network market size is projected to reach US$ 8125.7 million by 2026, from US$ 7581.9 million in 2020, at a CAGR of 6.6%% during 2021-2026. Global Body Area Network Scope and Market Size Body Area Network market is se…
- 体内超音波イメージング・センシングの世界市場（～2026年） This report is a customized report that about the field of intra-body Ultradound imaging and sensing. Readers can get high level overview of these markets from this report. Market Analysis and Insights: Global Intra-body Ultradound Imaging and Sensing Market The global Intra-body Ultradound Imaging …
- 髪・体用ミストの世界市場（～2026年） The natural body mist products use natural sources such as bergamot, cardamom, jasmine, musk, nutmeg, papaya, pineapple, and rose. Similarly, the natural hair mist products use natural sources such as corn, murumuru seed butter, black oat seeds, soybeans, coconut oil, olive oil, and honey. Some of t…